National Comprehensive Cancer Network



About NCCN

Head and Neck Cancers Panel - Disclosures as of 6/19/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Kie-Kian Ang, MD, PhD

None

Eli Lilly and Company

None

None

5/14/2012

David M. Brizel, MD

None

Siemens Molecular Imaging

None

None

4/26/2012

Barbara Burtness, MD

Bristol-Myers Squibb Company;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

Amgen Inc.

None

None

5/16/2012

Paul M. Busse, MD, PhD

None

None

None

None

6/6/2012

Jimmy J. Caudell, MD, PhD

None

None

None

None

6/3/2013

Anthony J. Cmelak, MD

None

Amgen Inc.

None

None

6/5/2012

A. Dimitrios Colevas, MD

Bayer HealthCare;
Boehringer Ingelheim GmbH;
Exelixis Inc.;
Genentech, Inc.;
GlaxoSmithKline;
actogenix;
ecog;
NCI;
rtog

None

None

None

6/11/2012

Frank Dunphy, MD

Bristol-Myers Squibb Company

None

None

None

6/1/2013

David W. Eisele, MD, FACS

None

None

None

None

3/20/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Jill Gilbert, MD

National Cancer Institute;
Eastern Cooperative Oncology Group

None

None

None

6/11/2012

Maura L. Gillison, MD, PhD

None

None

None

None

5/1/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Robert I. Haddad, MD

None

None

None

None

5/29/2013

Bruce H. Haughey, MBChB, MS

None

None

None

None

4/2/2013

Wesley L. Hicks, MD

None

None

None

None

3/1/2013

Ying J. Hitchcock, MD

None

None

None

None

10/1/2012

Miranda Hughes, PhD

None

None

None

None

4/10/2013

Antonio Jimeno, MD, PhD

        

Pending

Merrill S. Kies, MD

None

None

None

None

6/15/2012

William M. Lydiatt, MD

None

None

None

None

5/29/2013

Ellie Maghami, MD

None

None

None

None

6/5/2012

Renato Martins, MD, MPH

Bayer HealthCare;
Eisai Inc.;
Exelixis Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

None

4/8/2013

Thomas McCaffrey, MD, PhD

None

None

None

None

6/5/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Nicole McMillian, MS

None

None

None

None

3/27/2013

Loren K. Mell, MD

        

Pending

Bharat B. Mittal, MD

Genentech, Inc.

None

None

None

10/2/2012

David G. Pfister, MD

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Exelixis Inc.;
Genentech, Inc.;
ImClone Systems Incorporated;
Novartis Pharmaceuticals Corporation

None

None

None

8/13/2012

Harlan A. Pinto, MD

Bristol-Myers Squibb Company

Eli Lilly and Company

None

None

6/12/2012

John A. Ridge, MD, PhD, FACS

None

None

None

None

3/8/2013

Sandeep Samant, MD

None

None

None

None

8/9/2012

David E. Schuller, MD

None

None

None

National Cancer Institute

3/20/2013

Jatin P. Shah, MD, PhD

None

None

None

None

6/5/2012

Sharon Spencer, MD

None

None

None

None

8/9/2012

Randal S. Weber, MD

None

None

None

None

5/31/2013

Gregory Wolf, MD

None

None

None

None

10/11/2012

Frank Worden, MD

Pfizer Inc.

Bristol-Myers Squibb Company

None

None

10/2/2012

Sue S. Yom, MD, PhD

Genentech, Inc.

None

None

None

6/3/2013

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved